大戟科Casbane烷型二萜化合物的研究进展

本文综述了目前在自然界发现的Casbane烷型二萜化合物的结构特点、生物活性、分布状况和合成研究,同时针对文献中该类成分的骨架编号顺序混乱并造成化合物命名错误问题,我们采用J Buckingham的编号方法,对所有casbane烷型二萜化合物结构进行重新编号,对部分化合物命名进行修改.     

雷公藤植物内生Micromonospora sp. M66生产的一组吲哚生物碱

【目的】研究稀有放线菌——雷公藤内生小单孢菌(Micromonospora sp.M66)的次级代谢产物,为微生物药物或农用生物制剂开发提供结构多样的化合物资源。【方法】利用薄层层析、正(反)相硅胶柱层析、凝胶层析、液相色谱等技术对M66菌株中次级代谢产物进行分离纯化,利用波谱技术对化合物进行结构鉴定。【结果】最终分离纯化了7个单体化合物,结合质谱与核磁技术对这7个化合物进行了结构解析和鉴定,它们属于一组吲哚生物碱。化合物2是重要的植物生长调节剂,化合物3对淋巴细胞性白血病细胞P388、枯草芽孢杆菌和酿酒酵母的增殖有抑制作用,化合物6对金黄色葡萄球菌有很好的抑制作用。【结论】化合物3-7首次从小单胞菌中鉴定出来,表明该小单孢菌具有较强的利用吲哚或色氨酸合成次级代谢产物的能力和挖掘生物碱类药物的潜力。     

新结构硫脲类化合物的合成、鉴定及抑菌活性评价（英文）

【目的】合成具有抗菌活性的新结构硫脲类化合物。【方法】通过α-异硫氰酸酯中间体与不同伯胺缩合合成硫脲类化合物,利用质谱、核磁分析鉴定结构,并评价其抑菌活性。【结果】合成了六种新结构的硫脲类化合物以及一种α-异硫氰酸酯类衍生物,对几种代表性病原细菌和真菌具有抑菌活性。其中,硫脲类化合物对新型隐球菌的抑制效果较为显著。【结论】通过不同结构硫脲类衍生物的合成,可能筛选出具有抑制新型隐球菌等致病菌的前体化合物。     

新结构硫脲类化合物的合成、鉴定及抑菌活性评价

【目的】合成具有抗菌活性的新结构硫脲类化合物。【方法】通过α-异硫氰酸酯中间体与不同伯胺缩合合成硫脲类化合物,利用质谱、核磁分析鉴定结构,并评价其抑菌活性。【结果】合成了六种新结构的硫脲类化合物以及一种α-异硫氰酸酯类衍生物,对几种代表性病原细菌和真菌具有抑菌活性。其中,硫脲类化合物对新型隐球菌的抑制效果较为显著。【结论】通过不同结构硫脲类衍生物的合成,可能筛选出具有抑制新型隐球菌等致病菌的前体化合物。     

酰基苯肼化合物的结构与小麦锈病疗效的关系

1．合成了75种不同结构的酰基苯肼化合物,测定了其对小麦锈病的疗效．发现以、NHNHC—R 为基本结构的一些化合物是优良的小麦锈病化学治疗剂,其中有20种化合物在0．05—0．1％的浓度时,对小麦锈病有优良的防治效果。 2．比较了化合物结构与疗效之间的关系,结果表明结构的改变对疗效有很大的影响。 3．经过温室和田阆的反复药效测定,证明在酰基苯肼化合物中,p一甲酰苯肼(H40)疗效最好、药害轻微、结构简单、原料易得、制造与应用均较方便,是一个高效低毒的小麦锈病化学治疗剂。     

喹唑啉酮及其衍生物的生物学活性研究进展

喹唑啉酮类化合物是含有嘧啶杂环的一类重要化合物,最初是从真菌和细菌中分离得到的。喹唑啉酮化合物在抗菌、消炎、抗高血压、抗惊厥、抗肿瘤等方面均显示出良好的生物学活性。以喹唑啉酮为先导化合物,对其母体结构进行结构修饰与改造,设计、合成喹唑啉酮类衍生物并对其生物学活性进行筛选已成为有机化学的研究热点之一。本文对近些年来喹唑啉酮类化合物的生物学活性以及构效关系的研究进展进行了综述。     

丹皮酚及其结构类似物的修饰与抗炎活性研究

以丹皮酚及其结构类似物和布洛芬为原料,通过碳二亚胺法或酰氯法合成了五种化合物(A、B、C、D和E),其中化合物B、C、D和E为新化合物。化合物的结构经IR、1H-NMR及MS等测试技术表征确证。并用二甲苯致小鼠耳肿胀模型对其进行抗炎活性筛选。结果表明,化合物表现出明显的抗炎活性(P0.01)。     

珙桐科植物化学成分研究进展(综述)

本文概述从珙桐科植物中得到的数十种化合物的结构和波谱数据及药理活性,这些化合物大多结构新颖、具有较强生理活性,主要为喹啉类生物碱、吲哚类生物碱、鞣花酸类化合物、黄酮类化合物以及其它化合物。     

模拟α-螺旋多肽类似物抑制剂设计的研究进展

抑制剂筛选主要是通过反复、高通量地筛选化合物库,这个过程存在着对已有化合物库的依赖性和一定的机遇性。通过分析蛋白质数据库(PDB)发现,大多数蛋白质-蛋白质相互作用(PPI)界面以α-螺旋结构为主体。α-螺旋多肽的骨架结构及其热点氨基酸残基(hotspots)为高效理性设计小分子抑制剂提供了模板。对近几年来依据多肽类似物和小分子化合物模拟α-螺旋结构设计抑制剂的研究进展进行了概述,同时对依据模拟α-螺旋设计抑制剂骨架的结构原理进行了讨论。     

黄酮类化合物对大豆脂肪氧合酶的抑制作用研究

研究了几种不同黄酮化合物(黄酮醇类化合物、异黄酮类化合物、查尔酮类化合物、二氢黄酮类化合物)对大豆脂肪氧合酶(LOX)的抑制作用,并根据实验结果初步探讨了不同结构黄酮类化合物对大豆脂肪氧合酶抑制作用的结构-活性抑制作用关系.结果表明:黄酮化合物均可对LOX有不同程度的抑制作用,除橙皮苷外,它们的抑制效果均与加入量成正比,黄酮醇类化合物的抑制效果最为明显,它们对LOX的半数抑制浓度(IC50)依次为芦丁>槲皮素>根皮素>大豆黄素>异甘草素>芒柄花素>甘草素,而橙皮苷的最大抑制率为0.47 μg/mL时的45.1%.     

葡萄酒中重要挥发性硫化物的代谢及基因调控

葡萄酒中的挥发性硫化物是由酿酒微生物在葡萄酒发酵过程中代谢所产生的,主要包括硫化氢、硫醇、硫醚、硫醇酯、含硫杂醇油及杂环化合物等,它们对葡萄酒的风味会产生重要影响。本综述介绍了葡萄酒中重要的挥发性硫化物的主要代谢途径及相关基因的调控机制,并提出酿酒微生物的相关研究是提高优良风味物质含量,同时抑制不良风味产生的有效途径。     

Volatile Nitrogenous Compounds from Bacteria: Source of Novel Bioactive Compounds

Bacteria can produce nitrogenous compounds via both primary and secondary metabolic processes. Many bacterial volatile nitrogenous compounds produced during the secondary metabolism have been identified and reported for their antioxidant, antibacterial, antifungal, algicidal and antitumor activities. The production of these nitrogenous compounds depends on several factors, including the composition of culture media, growth conditions, and even the organic solvent used for their extraction, thus requiring their identification in specific conditions. In this review, we describe the volatile nitrogenous compounds produced by bacteria especially focusing on their antimicrobial activity. We concentrate on azo-compounds mainly pyrazines and pyrrolo-pyridines reported for their activity against several microorganisms. Whenever significant, extraction and identification methods of these compounds are also mentioned and discussed. To the best of our knowledge, this is first review describing volatile nitrogenous compounds from bacteria focusing on their biological activity.     

植物油基平台化合物及高分子材料研究进展

植物油作为最有希望的石油替代原料之一,已成为近年来的研究开发热点。文中介绍了植物油的分子结构及其对植物油基平台化合物和高分子材料性能的影响,进一步探讨了植物油基平台化合物及高分子材料的发展现状和最新研究进展;同时,概括性地介绍了当前植物油基平台化合物及高分子材料存在的主要问题,指出未来最有可能的研究方向,为更全面地了解植物油生物化工与发展前景提供参考。     

Recent syntheses of PI3K/Akt/mTOR signaling pathway inhibitors

This review focuses on the syntheses of PI3K/Akt/mTOR inhibitors that have been reported outside of the patent literature in the last 5 years but is largely centered on synthetic work reported in 2011 and 2012. While focused on syntheses of inhibitors, some information on in vitro and in vivo testing of compounds is also included. Many of these reported compounds are reversible, competitive adenosine triphosphate (ATP) binding inhibitors, so given the structural similarities of many of these compounds to the adenine core, this review presents recent work on inhibitors based on where the synthetic chemistry was started, that is, inhibitor syntheses which started with purines/pyrimidines are followed by inhibitor syntheses which began with pyridines, pyrazines, azoles, and triazines then moves to inhibitors which bear no structural resemblance to adenine: liphagal, wortmannin and quercetin analogs. The review then finishes with a short section on recent syntheses of phosphotidyl inositol (PI) analogs since competitive PI binding inhibitors represent an alternative to the competitive ATP binding inhibitors which have received the most attention.     

Biotechnology of flavonoids and other phenylpropanoid-derived natural products. Part I: Chemical diversity, impacts on plant biology and human health

Plant natural products derived from phenylalanine and the phenylpropanoid pathway are impressive in their chemical diversity and are the result of plant evolution, which has selected for the acquisition of large repertoires of pigments, structural and defensive compounds, all derived from a phenylpropanoid backbone via the plant-specific phenylpropanoid pathway. These compounds are important in plant growth, development and responses to environmental stresses and thus can have large impacts on agricultural productivity. While plant-based medicines containing phenylpropanoid-derived active components have long been used by humans, the benefits of specific flavonoids and other phenylpropanoid-derived compounds to human health and their potential for long-term health benefits have been only recognized more recently. In this part of the review, we discuss the diversity and biosynthetic origins of phenylpropanoids and particularly of the flavonoid and stilbenoid natural products. We then review data pertaining to the modes of action and biological properties of these compounds, referring on their effects on human health and physiology and their roles as plant defense and antimicrobial compounds. This review continues in Part II discussing the use of biotechnological tools targeting the rational reconstruction of multienzyme pathways in order to modify the production of such compounds in plants and model microbial systems for the benefit of agriculture and forestry.     

Allenic and cumulenic lipids

Nowadays, about 200 natural allenic metabolites, more than 2700 synthetic allenic compounds, and about 1300 cumulenic structures are known. The present review describes research on natural as well as some biological active allenic and cumulenic lipids and related compounds isolated from different sources. Intensive searches for new classes of pharmacologically potent agents produced by living organisms have resulted in the discovery of dozens of such compounds possessing high anticancer, cytotoxic, antibacterial, antiviral, and other activities. Known allenic and cumulenic compounds can be subdivided on several structural classes: fatty acids, hydrocarbons, terpenes, steroids, carotenoids, marine bromoallenes, peptides, aromatic, cumulenic, and miscellaneous compounds. This review emphasizes the role of natural and synthetic allenic and cumulenic lipids and other related compounds as an important source of leads for drug discovery.     

Biologically active metabolites of marine actinobacteria

Data on the chemical structures and biologic activities of metabolites of obligate and facultative marine actinobacteria published between 2000 and 2007 are reviewed. The structural features of five groups of metabolites related to macrolides and compounds containing lactone, quinone, and diketopiperazine residues; cyclic peptides; alkaloids; and compounds of combined nature are discussed. The review shows the large chemical diversity of metabolites of actinobacteria isolated from marine ecotopes. In addition to metabolites identical to those previously isolated from terrestrial actinobacteria, marine actinobacteria produce compounds not found in other natural sources, including microorganisms. Probably, the biosynthesis of new chemotypes of bioactive compounds by marine actinobacteria is related to the chemical adaptation of microorganisms to the marine environment. The review emphasizes the importance of chemical studies of metabolites produced by marine actinobacteria. These studies will provide new data on marine microbial producers of biologically active compounds and the chemical structures and biologic activities of new natural lowmolecular-weight bioregulators.     

Biodegradation of Aromatic Compounds by Escherichia coli

Although Escherichia coli has long been recognized as the best-understood living organism, little was known about its abilities to use aromatic compounds as sole carbon and energy sources. This review gives an extensive overview of the current knowledge of the catabolism of aromatic compounds by E. coli. After giving a general overview of the aromatic compounds that E. coli strains encounter and mineralize in the different habitats that they colonize, we provide an up-to-date status report on the genes and proteins involved in the catabolism of such compounds, namely, several aromatic acids (phenylacetic acid, 3- and 4-hydroxyphenylacetic acid, phenylpropionic acid, 3-hydroxyphenylpropionic acid, and 3-hydroxycinnamic acid) and amines (phenylethylamine, tyramine, and dopamine). Other enzymatic activities acting on aromatic compounds in E. coli are also reviewed and evaluated. The review also reflects the present impact of genomic research and how the analysis of the whole E. coli genome reveals novel aromatic catabolic functions. Moreover, evolutionary considerations derived from sequence comparisons between the aromatic catabolic clusters of E. coli and homologous clusters from an increasing number of bacteria are also discussed. The recent progress in the understanding of the fundamentals that govern the degradation of aromatic compounds in E. coli makes this bacterium a very useful model system to decipher biochemical, genetic, evolutionary, and ecological aspects of the catabolism of such compounds. In the last part of the review, we discuss strategies and concepts to metabolically engineer E. coli to suit specific needs for biodegradation and biotransformation of aromatics and we provide several examples based on selected studies. Finally, conclusions derived from this review may serve as a lead for future research and applications.     

Biodegradation of aromatic compounds by Escherichia coli.

Although Escherichia coli has long been recognized as the best-understood living organism, little was known about its abilities to use aromatic compounds as sole carbon and energy sources. This review gives an extensive overview of the current knowledge of the catabolism of aromatic compounds by E. coli. After giving a general overview of the aromatic compounds that E. coli strains encounter and mineralize in the different habitats that they colonize, we provide an up-to-date status report on the genes and proteins involved in the catabolism of such compounds, namely, several aromatic acids (phenylacetic acid, 3- and 4-hydroxyphenylacetic acid, phenylpropionic acid, 3-hydroxyphenylpropionic acid, and 3-hydroxycinnamic acid) and amines (phenylethylamine, tyramine, and dopamine). Other enzymatic activities acting on aromatic compounds in E. coli are also reviewed and evaluated. The review also reflects the present impact of genomic research and how the analysis of the whole E. coli genome reveals novel aromatic catabolic functions. Moreover, evolutionary considerations derived from sequence comparisons between the aromatic catabolic clusters of E. coli and homologous clusters from an increasing number of bacteria are also discussed. The recent progress in the understanding of the fundamentals that govern the degradation of aromatic compounds in E. coli makes this bacterium a very useful model system to decipher biochemical, genetic, evolutionary, and ecological aspects of the catabolism of such compounds. In the last part of the review, we discuss strategies and concepts to metabolically engineer E. coli to suit specific needs for biodegradation and biotransformation of aromatics and we provide several examples based on selected studies. Finally, conclusions derived from this review may serve as a lead for future research and applications.     

Sweetening agents of plant origin*

The most important sweet substance known is sucrose, which is obtained commercially from sugar cane and sugar beet. Because the intake of sucrose has been associated with a number of adverse effects on health, an intensive search has been undertaken to find alternative substances to satisfy the human craving for a sweet taste. Many other plant‐derived compounds are sweet, ranging in structural complexity from sugars and polyhydric alcohols through diterpene and triterpene glycosides to proteins; some of these compounds are intensely sweet, being hundreds or even thousand times sweeter than sucrose, and offer potential for commercial use in dietetic and diabetic foodstuffs. The present review examines the role of ethnobotany in the discovery of sweet‐tasting plants, the chemical isolation and elucidation of the sweet compounds, and some safety and sensory evaluation aspects of these compounds. A discussion on the future prospects of discovering and developing new plant‐derived sweeteners concludes the review.